TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/13/2026
Back to search
Official data from USPTO
CLEARA BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLEARA BIOTECH
ST13
US500000088190448Class
5, 42
Filing
88190448
Registration
5838152
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
08/13/2026
Trademark type
Word
Nice classes
5, 42
Filing date
11/12/2018
Registration date
08/20/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2026
Last transaction
08/13/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
26
Owner location
Utrecht, NL
Examiner
BIACHE, AUBREY
Current location
Historical data usage
Holders and representatives
Holders
C. B. (pessoa física)
Representatives
Stacy J. Grossman SGIP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Amino acids for medical purposes; Anti-cancer drugs; Biotechnological preparations for medical use for the treatment of benign and malignant tumorsage-related diseasesCOPDosteoarthritiskidney disease; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for use in oncology; peptides for medical purposessynthetic peptides for the treatment of benign and malignant tumorsage-related diseasesCOPDosteoarthritiskidney disease; medical preparations for the treatment of age-related diseases
Class 42
Scientific and technological services and researchscientific researchanalysistesting in the field of oncologybenign tumorstreatment of age-related diseasesCOPDosteoarthritiskidney disease; Biomedical research services; Medical research laboratory services; Development of pharmaceutical preparations and medicines; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Publications
History of USPTO decisions and trademark events.
42 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/13/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/13/2026
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/13/2026
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/13/2026
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
06/13/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/13/2026
ES8R
TEAS SECTION 8 RECEIVED
02/19/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/20/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/09/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/09/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/09/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/09/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/14/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/14/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/14/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/14/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/14/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/20/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2019
PUBO
PUBLISHED FOR OPPOSITION
06/04/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/15/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/30/2019
ALIE
ASSIGNED TO LIE
04/29/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/17/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
04/17/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/17/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
04/17/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/17/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/14/2019
GNFR
FINAL REFUSAL E-MAILED
04/14/2019
CNFR
FINAL REFUSAL WRITTEN
04/14/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/25/2019
GNRT
NON-FINAL ACTION E-MAILED
02/25/2019
CNRT
NON-FINAL ACTION WRITTEN
02/25/2019
DOCK
ASSIGNED TO EXAMINER
02/15/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/29/2018
NWAP
NEW APPLICATION ENTERED
11/15/2018
Continuous trademark protection
Get notified about every new filing that threatens CLEARA BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.